MJA InSight ARTICLE
Triple drug therapy for newly diagnosed myeloma – when is more, better?
Authored by: Professor H. Miles Prince AM, Director of Cancer Immunology & Molecular Oncology, Epworth Healthcare
MJA InSight ARTICLE
Triple drug therapy for newly diagnosed myeloma – when is more, better?
Authored by: Professor H. Miles Prince AM, Director of Cancer Immunology & Molecular Oncology, Epworth Healthcare